Tempus AI, Inc. (NASDAQ:TEM) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM) have been given an average rating of “Moderate Buy” by the eleven brokerages that are presently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $56.20.

A number of research analysts have weighed in on TEM shares. Guggenheim initiated coverage on Tempus AI in a report on Monday. They set a “buy” rating and a $74.00 target price for the company. Bank of America cut Tempus AI from a “buy” rating to a “neutral” rating and upped their price objective for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Piper Sandler reaffirmed a “neutral” rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and boosted their price objective for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Finally, Loop Capital increased their target price on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th.

Tempus AI Stock Down 2.8 %

Shares of TEM stock opened at $41.99 on Friday. The stock has a 50-day moving average of $52.88. Tempus AI has a 52 week low of $22.89 and a 52 week high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Insider Buying and Selling

In related news, major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the completion of the sale, the insider now directly owns 16,164,449 shares in the company, valued at $694,263,084.55. This represents a 2.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Hedge Funds Weigh In On Tempus AI

Several hedge funds have recently modified their holdings of the stock. First Horizon Advisors Inc. acquired a new position in shares of Tempus AI in the 3rd quarter valued at about $30,000. Sandia Investment Management LP purchased a new position in shares of Tempus AI during the 2nd quarter valued at approximately $136,000. Vestor Capital LLC acquired a new stake in shares of Tempus AI in the third quarter valued at about $153,000. Stifel Financial Corp purchased a new stake in Tempus AI during the 3rd quarter worth approximately $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new stake in shares of Tempus AI during the third quarter worth approximately $258,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.